Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor

This case suggests that anlotinib combined with radiotherapy may be an effective therapeutic option for advanced MMNST, providing valuable clinical evidence for managing this malignancy.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-02-03
DOI
https://doi.org/10.3389/fonc.2026.1680441
Primary Topic
Neurofibromatosis and Schwannoma Cases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor

Han Yang, Yong Tan, Y. Zhang, Jinling Xie et al.
Frontiers in Oncology
Neurofibromatosis and Schwannoma Cases
article

Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor

Han Yang, Yong Tan, Y. Zhang, Jinling Xie, P. Lu, Y. Ji, W. H. Shen, Huizhan Zhu, Xiaoyang Han, Weiwei Li
article en

Abstract

This case suggests that anlotinib combined with radiotherapy may be an effective therapeutic option for advanced MMNST, providing valuable clinical evidence for managing this malignancy.

Frontiers in OncologyVol. 16
First Affiliated Hospital of Xinxiang Medical University (CN), Henan Medical University (CN)
Good health and well-being
Openalex Percentile: Top 70%
Neurofibromatosis and Schwannoma Cases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.